Hyundai Pharmaceutical Co. Ltd.
Hyundai Pharmaceutical Co. Ltd. operates in Diversified Metals & Mining.
Hyundai Pharmaceutical Co. Ltd. (004310) - Net Assets
Latest net assets as of : ₩- KRW
Based on the latest financial reports, Hyundai Pharmaceutical Co. Ltd. (004310) has net assets worth ₩- KRW as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩-) and total liabilities (₩-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Hyundai Pharmaceutical Co. Ltd. - Net Assets Trend (None–None)
This chart illustrates how Hyundai Pharmaceutical Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Hyundai Pharmaceutical Co. Ltd. (None–None)
The table below shows the annual net assets of Hyundai Pharmaceutical Co. Ltd. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Hyundai Pharmaceutical Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Hyundai Pharmaceutical Co. Ltd. Competitors by Market Cap
The table below lists competitors of Hyundai Pharmaceutical Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AEM
AT:AEM
|
$58.77K |
|
CITYDEV (CDE.SG)
STU:CDE
|
$58.82K |
|
Signet EV Inc
KO:260870
|
$58.90K |
|
Viromed Medical AG
DU:Q11
|
$58.92K |
|
Korea Kolmar Holdings Co. Ltd.
KQ:024720
|
$58.68K |
|
Deutsche Grundstücksauktionen AG
XETRA:DGR
|
$58.66K |
|
Daesung Holdings Co. Ltd.
KQ:016710
|
$58.56K |
|
MFS Charter Income Trust
NYSE:MCR
|
$58.55K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hyundai Pharmaceutical Co. Ltd.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Hyundai Pharmaceutical Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Hyundai Pharmaceutical Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Hyundai Pharmaceutical Co. Ltd.'s net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $101,285,795,421
- Average return on equity (ROE) among peers: -24.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hyundai Pharmaceutical Co. Ltd. (004310) | ₩- | N/A | N/A | $58.71K |
| Kukyoung G&M (006050) | $51.01 Billion | -2.56% | 0.37x | $8.37K |
| Kossen Co Ltd (009730) | $14.31 Billion | -212.62% | 2.32x | $3.71K |
| Haansoft (030520) | $549.72 Billion | 3.28% | 0.54x | $147.64K |
| BIT Computer (032850) | $54.93 Billion | 11.85% | 0.29x | $31.44K |
| Plumb Fast Co (035200) | $29.09 Billion | 11.02% | 0.35x | $21.53K |
| A-Frontier Co. Ltd. (036180) | $25.85 Billion | 16.56% | 0.27x | $3.84K |
| Infraware (041020) | $36.71 Billion | -39.68% | 0.21x | $29.45K |
| Kook Soon Dang Co. Ltd. (043650) | $215.68 Billion | -1.25% | 0.11x | $25.25K |
| Stcube (052020) | $38.70 Billion | -27.66% | 0.51x | $49.27K |
| Fourth-Link Inc. (056730) | $-3.13 Billion | 0.00% | 0.00x | $2.96K |